jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

April. 29, 2023

April. 29, 2023

jRCT1011230004

Establishment of a method to measure the concentration of protein non-binding remimazolam

Measurement of the concentration of free remimazolam

Yoshikawa Yusuke

Sapporo Medical University

South1 West17 Chuoku Sapporo

+81-11-688-9663

y.yoshikawa@sapmed.ac.jp

Yoshikawa Yusuke

Sapporo Medical University

South1 West17 Chuoku Sapporo

+81-11-688-9663

y.yoshikawa@sapmed.ac.jp

Recruiting

April. 29, 2023

5

Observational

Equal to or older than 20 years old
Patients who receive cardiovascular surgery under cardiopulmonary bypass with remimazolam

Refusal to participate
Emergent case
Allergy against remimazolam
Acute angle closure glaucoma
Myasthenia gravis
Hepatic failure (Child Pugh equal to or more than 2)
Renal failure (sCre equal to or more than 2 mg/dL)
Obesity (BMI equal to or more than 35 kg/m2)
Deep hypothermic circulatory arrest
Patients who are considered to be inappropriate to participate to the study

201age old over
No limit

Both

Cardiocascular surgery

Concentration of free remimazolam

Concentration of total remimazolam, a metabolite of remimazolam (CNS7054), and albumin
Protein binding ratio of remimazolam

The Institutional Review Board of Sapporo Medical University Hospital
South 1, West 16, 291, Chuo-ku, Sapporo, Hokkaido, Hokkaido, Hokkaido

+81-11-611-2111

ji-rskk@sapmed.ac.jp
Approval

Mar. 09, 2023

No

none